|
HY-17387-1mL
|
MedChemexpress LLC
|
(-)-Huperzine A [CAS 102518-79-6] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-12307-1mg
|
MedChemexpress LLC
|
(-)-Indolactam V [CAS 90365-57-4]
|
|
Cancer-Kinase/protease
|
|
|
HY-12307-5mg
|
MedChemexpress LLC
|
(-)-Indolactam V [CAS 90365-57-4]
|
|
Cancer-Kinase/protease
|
|
|
HY-12307-1mL
|
MedChemexpress LLC
|
(-)-Indolactam V [CAS 90365-57-4] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
|
HY-139602C-10mg
|
MedChemexpress LLC
|
(-)-JNJ-A07 [CAS 2135640-92-3]
|
|
COVID-19-anti-virus
|
|
|
HY-139602C-100mg
|
MedChemexpress LLC
|
(-)-JNJ-A07 [CAS 2135640-92-3]
|
|
COVID-19-anti-virus
|
|
|
HY-139602C-25mg
|
MedChemexpress LLC
|
(-)-JNJ-A07 [CAS 2135640-92-3]
|
|
COVID-19-anti-virus
|
|
|
HY-139602C-5mg
|
MedChemexpress LLC
|
(-)-JNJ-A07 [CAS 2135640-92-3]
|
|
COVID-19-anti-virus
|
|
|
HY-139602C-50mg
|
MedChemexpress LLC
|
(-)-JNJ-A07 [CAS 2135640-92-3]
|
|
COVID-19-anti-virus
|
|
|
HY-139602C-1mL
|
MedChemexpress LLC
|
(-)-JNJ-A07 [CAS 2135640-92-3] (10mM in DMSO)
|
|
COVID-19-anti-virus
|
|
|
HY-100443B-1mg
|
MedChemexpress LLC
|
(-)-PX20606 (trans isomer) [CAS 1268244-88-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-100443B-2mg
|
MedChemexpress LLC
|
(-)-PX20606 (trans isomer) [CAS 1268244-88-7]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-123352A-10mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-123352A-100mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-123352A-25mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-123352A-5mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-123352A-50mg
|
MedChemexpress LLC
|
(-)-ZK 216348
|
|
|
|
|
HY-13030-1g
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-10mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-100mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-2mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-5mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-50mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-500mg
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4]
|
|
Cancer-programmed cell death
|
|
|
HY-13030-1mL
|
MedChemexpress LLC
|
(+)-JQ-1 [CAS 1268524-70-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
